Skip to content

Clinical trials

Phase 3 Lymphoma, Mantle-Cell trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 3 Country / region: Sweden Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20132
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC3
European Organisation for Research and Treatment of Cancer - EORTC1
Gilead Sciences1
Prof. Dr. M. Dreyling (co-chairman)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell6
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Follicular3
Lymphoma, Large B-Cell, Diffuse3
Burkitt Lymphoma2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Large-Cell, Immunoblastic2
Lymphoma, Non-Hodgkin2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Waldenstrom Macroglobulinemia2

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.